InvestorsHub Logo
Followers 91
Posts 17201
Boards Moderated 0
Alias Born 09/06/2006

Re: Looking4aprofit post# 139639

Friday, 10/20/2017 9:53:17 AM

Friday, October 20, 2017 9:53:17 AM

Post# of 689585

Notice the subtle change in direction by our resident naysayers?


Nope.

We may get another round of dilution but remember, we can expect an income stream soon from rents. Financial institutions WILL lend against current cash flows as opposed to a "possible" drug approval, hence the need for the recent round toxic financings to keep the "lights on" shorties failed, again.


$1.4M a year will cover less than one month of spend. Maybe they can even find a way to sell the rent stream for $3-4M or something. That keeps the lights on for 2 months. The next financing is imminent, the R/S and/or auth share limit vote is a month from being announced, and the raises will go on.

We are close to the finishing line and they are trying to tell you about valuation models etc....hello?


Are you? Senti argues they will keep the data blinded until all the OS data is in. That could be a decade or more. The blended data will do nothing for the PPS or FDA. NWBO is not even talking about releasing real trial results any more.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News